Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948492035> ?p ?o ?g. }
- W2948492035 endingPage "113" @default.
- W2948492035 startingPage "93" @default.
- W2948492035 abstract "Most human cancers respond poorly to conventional therapeutics, and those that respond develop resistance to subsequent treatments. It has been reported that in many, but not all, studied cancers, there exists a mini population of cancer stem cells (CSCs) that is highly drug resistant and that its survival leads to recurrences and metastases. Hence, new targeted therapies directed at CSCs have been the subject of many investigations, and several agents are currently being investigated clinically. Several transcription factors are overexpressed in CSCs (e.g., SOX2, OCT4, NANOG, BMI1) that regulate stemness such as pluripotency and also regulate drug resistance. The transcription factor Yin Yang 1 (YY1) has been reported to be overexpressed in many cancers and is associated with cell proliferation, viability, EMT, metastasis, and chemo-immune resistance. Due to many common features of YY1 activities and cancer stem cell transcription factors, it was hypothesized that a crosstalk may exist between YY1 and CSCs transcription factors. Proteomic analysis was performed for the expression of YY1, SOX2, OCT4, and BM1 and delineated the presence of four groups of cancers with different molecular signatures consisting of different levels of expression of the above four transcription factors. These findings supported the hypothesis that YY1 is involved in the regulation of cancer stem cell transcription factors and their roles in resistance. Thus, targeting YY1 alone may be considered as a new therapeutic approach when used alone or in combination with various conventional or novel drugs to reverse cancer resistance in patients." @default.
- W2948492035 created "2019-06-14" @default.
- W2948492035 creator A5055490703 @default.
- W2948492035 date "2019-01-01" @default.
- W2948492035 modified "2023-09-27" @default.
- W2948492035 title "Overexpression of YY1 Regulates the Resistance of Cancer Stem Cells: Targeting YY1" @default.
- W2948492035 cites W1147349766 @default.
- W2948492035 cites W1514208610 @default.
- W2948492035 cites W1575185537 @default.
- W2948492035 cites W1600624515 @default.
- W2948492035 cites W1640700074 @default.
- W2948492035 cites W1781390342 @default.
- W2948492035 cites W1964427001 @default.
- W2948492035 cites W1965581435 @default.
- W2948492035 cites W1966217032 @default.
- W2948492035 cites W1968106721 @default.
- W2948492035 cites W1975305152 @default.
- W2948492035 cites W1976792933 @default.
- W2948492035 cites W1989604393 @default.
- W2948492035 cites W1992424594 @default.
- W2948492035 cites W1994928797 @default.
- W2948492035 cites W2002013266 @default.
- W2948492035 cites W2008674168 @default.
- W2948492035 cites W2008955962 @default.
- W2948492035 cites W2009906157 @default.
- W2948492035 cites W2012034410 @default.
- W2948492035 cites W2012288070 @default.
- W2948492035 cites W2013497246 @default.
- W2948492035 cites W2019009111 @default.
- W2948492035 cites W2028593825 @default.
- W2948492035 cites W2037066451 @default.
- W2948492035 cites W2037100155 @default.
- W2948492035 cites W2037468156 @default.
- W2948492035 cites W2039767026 @default.
- W2948492035 cites W2042198997 @default.
- W2948492035 cites W2042644330 @default.
- W2948492035 cites W2048346637 @default.
- W2948492035 cites W2049400611 @default.
- W2948492035 cites W2053699199 @default.
- W2948492035 cites W2062069198 @default.
- W2948492035 cites W2064044156 @default.
- W2948492035 cites W2066824183 @default.
- W2948492035 cites W2067311782 @default.
- W2948492035 cites W2068710524 @default.
- W2948492035 cites W2074725580 @default.
- W2948492035 cites W2074808378 @default.
- W2948492035 cites W2077587951 @default.
- W2948492035 cites W2082175263 @default.
- W2948492035 cites W2082496903 @default.
- W2948492035 cites W2084865991 @default.
- W2948492035 cites W2087120053 @default.
- W2948492035 cites W2095424699 @default.
- W2948492035 cites W2095586341 @default.
- W2948492035 cites W2097308038 @default.
- W2948492035 cites W2102394111 @default.
- W2948492035 cites W2104632240 @default.
- W2948492035 cites W2107575419 @default.
- W2948492035 cites W2108451330 @default.
- W2948492035 cites W2108686626 @default.
- W2948492035 cites W2108784887 @default.
- W2948492035 cites W2109260671 @default.
- W2948492035 cites W2126541203 @default.
- W2948492035 cites W2126851387 @default.
- W2948492035 cites W2127107445 @default.
- W2948492035 cites W2131848047 @default.
- W2948492035 cites W2134550928 @default.
- W2948492035 cites W2138778346 @default.
- W2948492035 cites W2140350596 @default.
- W2948492035 cites W2142106789 @default.
- W2948492035 cites W2143570904 @default.
- W2948492035 cites W2147599664 @default.
- W2948492035 cites W2154185970 @default.
- W2948492035 cites W2158255028 @default.
- W2948492035 cites W2161080156 @default.
- W2948492035 cites W2161871502 @default.
- W2948492035 cites W2297970061 @default.
- W2948492035 cites W2331501451 @default.
- W2948492035 cites W2344074251 @default.
- W2948492035 cites W2365209119 @default.
- W2948492035 cites W2395905799 @default.
- W2948492035 cites W2399921918 @default.
- W2948492035 cites W2479587588 @default.
- W2948492035 cites W2489799127 @default.
- W2948492035 cites W2513022266 @default.
- W2948492035 cites W2537413785 @default.
- W2948492035 cites W2539397301 @default.
- W2948492035 cites W2556199306 @default.
- W2948492035 cites W2560385907 @default.
- W2948492035 cites W2567986926 @default.
- W2948492035 cites W2578249237 @default.
- W2948492035 cites W2580091136 @default.
- W2948492035 cites W2586412573 @default.
- W2948492035 cites W2588141820 @default.
- W2948492035 cites W2591706849 @default.
- W2948492035 cites W2593074826 @default.
- W2948492035 cites W2593316971 @default.
- W2948492035 cites W2595295013 @default.
- W2948492035 cites W2599212387 @default.